Ad
related to: translocating nad p transhydrogenase time period chart for pregnancy
Search results
Results From The WOW.Com Content Network
NADPH is used as a reducing agent in many anabolic reactions. Proton translocating NAD(P) + transhydrogenase is one of the main ways that cells can regenerate NADPH after it is used. In E. coli, this pathway contribute equal amounts of NADPH as the pentose phosphate pathway, and both were the main producers of NADPH under standard growth ...
This list contains a list of sub-classes for the seventh group of Enzyme Commission numbers, EC 7, translocases, placed in numerical order as determined by the Nomenclature Committee of the International Union of Biochemistry and Molecular Biology.
Transhydrogenase may stand for NAD(P)+ transhydrogenase (Re/Si-specific) NAD(P)+ transhydrogenase (Si-specific) Proton-Translocating NAD(P)+ Transhydrogenase; Hydroxyacid-oxoacid transhydrogenase; Glutathione—cystine transhydrogenase; Lactate—malate transhydrogenase; Glutathione—homocystine transhydrogenase; Glutathione—CoA-glutathione ...
Nicotinamide adenine dinucleotide phosphate, abbreviated NADP [1] [2] or, in older notation, TPN (triphosphopyridine nucleotide), is a cofactor used in anabolic reactions, such as the Calvin cycle and lipid and nucleic acid syntheses, which require NADPH as a reducing agent ('hydrogen source').
In biochemistry, NAD(P) + transhydrogenase (Si-specific) (EC 1.6.1.1) is an enzyme that catalyzes the chemical reaction. NADPH + NAD + NADP + + NADH. Thus, the two substrates of this enzyme are NADPH and NAD +, whereas its two products are NADP + and NADH. This enzyme participates in nicotinate and nicotinamide metabolism.
NAD(P) transhydrogenase, mitochondrial is an enzyme that in humans is encoded by the NNT gene on chromosome 5. [ 5 ] [ 6 ] [ 7 ] The NNT gene contains 26 exons and encodes a transhydrogenase protein that is ~109 kDa in molecular weight and is involved in antioxidant defense in the mitochondria .
Women are 4-5 times more likely to develop a clot during pregnancy and in the postpartum period than when they are not pregnant. [25] Hypercoagulability in pregnancy likely evolved to protect women from hemorrhage at the time of miscarriage or childbirth. In developing countries, the leading cause of maternal death is still hemorrhage. [25]
NAD(P)+ transhydrogenase (Si-specific) This page was last edited on 28 May 2015, at 13:20 (UTC). Text is available under the Creative Commons Attribution ...